Gliadin Peptide P31-43 and Its Role in Celiac Disease
Author Information
Author(s): Barone M. Vittoria, Zanzi Delia, Maglio Mariantonia, Nanayakkara Merlin, Santagata Sara, Lania Giuliana, Miele Erasmo, Ribecco Maria Teresa Silvia, Maurano Francesco, Auricchio Renata, Gianfrani Carmen, Ferrini Silvano, Troncone Riccardo, Auricchio Salvatore
Primary Institution: Department of Pediatrics and European Laboratory for the Investigation of Food-Induced Diseases (ELFID), University of Naples Federico II, Naples, Italy
Hypothesis
Does the gliadin peptide P31-43 induce cellular proliferation and innate immune activation in celiac disease?
Conclusion
P31-43 induces an increase in IL-15 on cell surfaces and promotes proliferation of crypt enterocytes, contributing to the remodeling of the celiac mucosa.
Supporting Evidence
- P31-43 increased the percentage of BrdU-positive cells in CaCo-2 cells from 26.40% to 44.33%.
- Blocking IL-15 and EGFR reduced the percentage of proliferating cells significantly.
- IL-15 levels increased on the cell surface after treatment with P31-43.
Takeaway
A piece of gluten called P31-43 makes certain cells in the gut grow more and activates the immune system, which can cause problems for people with celiac disease.
Methodology
Cell proliferation was measured using BrdU incorporation in CaCo-2 cells and biopsies from celiac disease patients, along with real-time PCR and various protein assays.
Limitations
The study primarily focuses on in vitro models and may not fully represent in vivo conditions.
Participant Demographics
Biopsies from five untreated patients with active celiac disease and three controls with gastroesophageal reflux.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website